Figure 1From: Efficacy of lisdexamfetamine dimesylate in adults with attention-deficit/hyperactivity disorder previously treated with amphetamines: analyses from a randomized, double-blind, multicenter, placebo-controlled titration study Mean (SD) ADHD-RS-IV total scores for prior AMPH LDX-treated subgroup and overall efficacy population. Back to article page